2676211-64-4

2676211-64-4 structure

Name: FHD-609
Chemical Name: FHD-609
CAS Number: 2676211-64-4
Molecular Formula: C₄₇H₅₆N₈O₆
Molecular Weight: 829.00
Catalog: Signaling Pathways Epigenetics Epigenetic Reader Domain
Create Date: 2023-06-23 23:34:22
Modify Date: 2024-01-13 13:43:11
FHD-609 is an inhibitor and a degrader of BRD9 (bromodomain-containing protein 9). FHD-609 targets to ncBAF, can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment[1][2].

Name	FHD-609

Description	FHD-609 is an inhibitor and a degrader of BRD9 (bromodomain-containing protein 9). FHD-609 targets to ncBAF, can be used for research of wide range of cancers that contain a mutation in a BAF complex subunit. FHD-609 in combination with Telomelysin or INO5401, may play a role in adrenocortical carcinoma (ACC) treatment[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Epigenetics >> Epigenetic Reader Domain
Target	BRD9
References	[1]. Rechberger JS, et al. Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets. Expert Opin Ther Targets. 2022 Mar;26(3):187-192. [2]. Hescheler DA, et al. Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options. Cancers (Basel). 2022 May 31;14(11):2721.

Molecular Formula	C₄₇H₅₆N₈O₆
Molecular Weight	829.00